• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中的RNA修饰

RNA modifications in cancer.

作者信息

Wu Han, Chen Shi, Li Xiang, Li Yuyang, Shi He, Qing Yiwen, Shi Bohe, Tang Yifei, Yan Zhuoyi, Hao Yang, Wang Dongxu, Liu Weiwei

机构信息

Department of Oral and Maxillofacial Surgery Hospital of Stomatology Jilin University, Changchun Jilin province China.

Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling Hospital of Stomatology Jilin University, Changchun Jilin provincle China.

出版信息

MedComm (2020). 2025 Jan 10;6(1):e70042. doi: 10.1002/mco2.70042. eCollection 2025 Jan.

DOI:10.1002/mco2.70042
PMID:39802639
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11718328/
Abstract

RNA modifications are emerging as critical cancer regulators that influence tumorigenesis and progression. Key modifications, such as N6-methyladenosine (mA) and 5-methylcytosine (mC), are implicated in various cellular processes. These modifications are regulated by proteins that write, erase, and read RNA and modulate RNA stability, splicing, translation, and degradation. Recent studies have highlighted their roles in metabolic reprogramming, signaling pathways, and cell cycle control, which are essential for tumor proliferation and survival. Despite these scientific advances, the precise mechanisms by which RNA modifications affect cancer remain inadequately understood. This review comprehensively examines the role RNA modifications play in cancer proliferation, metastasis, and programmed cell death, including apoptosis, autophagy, and ferroptosis. It explores their effects on epithelial-mesenchymal transition (EMT) and the immune microenvironment, particularly in cancer metastasis. Furthermore, RNA modifications' potential in cancer therapies, including conventional treatments, immunotherapy, and targeted therapies, is discussed. By addressing these aspects, this review aims to bridge current research gaps and underscore the therapeutic potential of targeting RNA modifications to improve cancer treatment strategies and patient outcomes.

摘要

RNA修饰正逐渐成为影响肿瘤发生和进展的关键癌症调节因子。关键修饰,如N6-甲基腺苷(mA)和5-甲基胞嘧啶(mC),参与多种细胞过程。这些修饰由写入、擦除和读取RNA的蛋白质调控,并调节RNA的稳定性、剪接、翻译和降解。最近的研究强调了它们在代谢重编程、信号通路和细胞周期控制中的作用,这些对肿瘤增殖和存活至关重要。尽管有这些科学进展,但RNA修饰影响癌症的确切机制仍未得到充分理解。本综述全面探讨了RNA修饰在癌症增殖、转移和程序性细胞死亡(包括凋亡、自噬和铁死亡)中的作用。它探讨了它们对上皮-间质转化(EMT)和免疫微环境的影响,特别是在癌症转移方面。此外,还讨论了RNA修饰在癌症治疗中的潜力,包括传统治疗、免疫治疗和靶向治疗。通过阐述这些方面,本综述旨在弥补当前研究空白,并强调靶向RNA修饰以改善癌症治疗策略和患者预后的治疗潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae6/11718328/f7103566b5d5/MCO2-6-e70042-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae6/11718328/7e938d41484d/MCO2-6-e70042-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae6/11718328/ffa2a742dfe8/MCO2-6-e70042-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae6/11718328/324e442e9a6c/MCO2-6-e70042-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae6/11718328/a55a96ccc1c6/MCO2-6-e70042-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae6/11718328/038b4fd14b62/MCO2-6-e70042-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae6/11718328/78ffde2d8d82/MCO2-6-e70042-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae6/11718328/f7103566b5d5/MCO2-6-e70042-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae6/11718328/7e938d41484d/MCO2-6-e70042-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae6/11718328/ffa2a742dfe8/MCO2-6-e70042-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae6/11718328/324e442e9a6c/MCO2-6-e70042-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae6/11718328/a55a96ccc1c6/MCO2-6-e70042-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae6/11718328/038b4fd14b62/MCO2-6-e70042-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae6/11718328/78ffde2d8d82/MCO2-6-e70042-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ae6/11718328/f7103566b5d5/MCO2-6-e70042-g001.jpg

相似文献

1
RNA modifications in cancer.癌症中的RNA修饰
MedComm (2020). 2025 Jan 10;6(1):e70042. doi: 10.1002/mco2.70042. eCollection 2025 Jan.
2
N6-methyladenosine RNA methylation, a new hallmark of metabolic reprogramming in the immune microenvironment.N6-甲基腺苷RNA甲基化,免疫微环境中代谢重编程的一个新标志。
Front Immunol. 2024 Dec 20;15:1464042. doi: 10.3389/fimmu.2024.1464042. eCollection 2024.
3
Role of N6-methyladenosine RNA modification in cancer.N6-甲基腺苷RNA修饰在癌症中的作用。
MedComm (2020). 2024 Sep 9;5(9):e715. doi: 10.1002/mco2.715. eCollection 2024 Sep.
4
N6-methyladenosine modification and post-translational modification of epithelial-mesenchymal transition in colorectal cancer.N6-甲基腺苷修饰与结直肠癌上皮-间质转化的翻译后修饰
Discov Oncol. 2024 Jun 4;15(1):209. doi: 10.1007/s12672-024-01048-3.
5
Surmounting cancer drug resistance: New insights from the perspective of N-methyladenosine RNA modification.克服癌症药物耐药性:N6-甲基腺苷 RNA 修饰视角的新见解。
Drug Resist Updat. 2020 Dec;53:100720. doi: 10.1016/j.drup.2020.100720. Epub 2020 Aug 20.
6
Pharmacology of epitranscriptomic modifications: Decoding the therapeutic potential of RNA modifications in drug resistance.表观转录组修饰的药理学:解读RNA修饰在耐药性中的治疗潜力
Eur J Pharmacol. 2025 May 5;994:177397. doi: 10.1016/j.ejphar.2025.177397. Epub 2025 Feb 18.
7
Epitranscriptomics and cervical cancer: the emerging role of mA, mC and mA RNA modifications.表观转录组学与宫颈癌:m~A、m~C 和 m~A RNA 修饰的新兴作用。
Expert Rev Mol Med. 2024 Oct 8;26:e20. doi: 10.1017/erm.2024.20.
8
Modifications of RNA in cancer: a comprehensive review.癌症中RNA的修饰:全面综述
Mol Biol Rep. 2025 Mar 17;52(1):321. doi: 10.1007/s11033-025-10419-0.
9
N6-methyladenosine RNA modification in stomach carcinoma: Novel insights into mechanisms and implications for diagnosis and treatment.胃癌中的N6-甲基腺苷RNA修饰:机制的新见解及其对诊断和治疗的意义
Biochim Biophys Acta Mol Basis Dis. 2025 Jun;1871(5):167793. doi: 10.1016/j.bbadis.2025.167793. Epub 2025 Mar 14.
10
Writers, readers, and erasers RNA modifications and drug resistance in cancer.RNA 修饰与癌症的药物耐药性:作者、读者和橡皮擦
Mol Cancer. 2024 Aug 30;23(1):178. doi: 10.1186/s12943-024-02089-6.

本文引用的文献

1
Pseudouridine guides germline small RNA transport and epigenetic inheritance.假尿苷引导种系小RNA转运和表观遗传继承。
Nat Struct Mol Biol. 2025 Feb;32(2):277-286. doi: 10.1038/s41594-024-01392-6. Epub 2024 Sep 6.
2
WTAP/YTHDF1-mediated mA modification amplifies IFN-γ-induced immunosuppressive properties of human MSCs.WTAP/YTHDF1介导的N⁶-甲基腺苷修饰增强了干扰素-γ诱导的人骨髓间充质干细胞的免疫抑制特性。
J Adv Res. 2025 May;71:441-455. doi: 10.1016/j.jare.2024.06.019. Epub 2024 Jun 27.
3
The role of RNA methylation in tumor immunity and its potential in immunotherapy.
RNA 甲基化在肿瘤免疫中的作用及其在免疫治疗中的潜力。
Mol Cancer. 2024 Jun 20;23(1):130. doi: 10.1186/s12943-024-02041-8.
4
Photosensitive and dual-targeted chromium nanoparticle delivering small interfering RNA YTHDF1 for molecular-targeted immunotherapy in liver cancer.载有小干扰 RNA YTHDF1 的光敏双靶向铬纳米颗粒用于肝癌的分子靶向免疫治疗。
J Nanobiotechnology. 2024 Jun 19;22(1):348. doi: 10.1186/s12951-024-02612-3.
5
Metabolic Recoding of NSUN2-Mediated mC Modification Promotes the Progression of Colorectal Cancer via the NSUN2/YBX1/mC-ENO1 Positive Feedback Loop.NSUN2 介导的 mC 修饰的代谢重编程通过 NSUN2/YBX1/mC-ENO1 正反馈环促进结直肠癌的进展。
Adv Sci (Weinh). 2024 Jul;11(28):e2309840. doi: 10.1002/advs.202309840. Epub 2024 May 20.
6
Converting "cold" to "hot": epigenetics strategies to improve immune therapy effect by regulating tumor-associated immune suppressive cells.将“冷”转化为“热”:通过调节肿瘤相关免疫抑制细胞来改善免疫治疗效果的表观遗传学策略。
Cancer Commun (Lond). 2024 Jun;44(6):601-636. doi: 10.1002/cac2.12546. Epub 2024 May 7.
7
Small Molecule-Inducible and Photoactivatable Cellular RNA N1-Methyladenosine Editing.小分子诱导和光活化的细胞 RNA N1-甲基腺苷编辑。
Angew Chem Int Ed Engl. 2024 Jun 21;63(26):e202320029. doi: 10.1002/anie.202320029. Epub 2024 May 16.
8
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
9
Immunologic tumor microenvironment modulators for turning cold tumors hot.免疫肿瘤微环境调节剂可使冷肿瘤变热。
Cancer Commun (Lond). 2024 May;44(5):521-553. doi: 10.1002/cac2.12539. Epub 2024 Mar 29.
10
NSUN5/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion.NSUN5/TET2 靶向染色质相关 RNA 修饰 5-甲基胞嘧啶为 5-羟甲基胞嘧啶,调控胶质瘤免疫逃逸。
Proc Natl Acad Sci U S A. 2024 Apr 2;121(14):e2321611121. doi: 10.1073/pnas.2321611121. Epub 2024 Mar 28.